Macroview Investment Management LLC Viatris Inc Transaction History

Macroview Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 30, 2024	SELL	$11.27 - $13.53 $23,464 - $28,169	-2,082 Reduced 98.49%	32 $0
Q4 2023 Jan 30, 2024	SELL	$8.77 - $10.85 $5,761 - $7,128	-657 Reduced 23.71%	2,114 $22,000
Q3 2023 Oct 26, 2023	BUY	$9.59 - $11.35 $6,770 - $8,013	706 Added 34.19%	2,771 $27,000
Q2 2023 Jul 13, 2023	SELL	$9.02 - $10.29 $126 - $144	-14 Reduced 0.67%	2,065 $20,000
Q1 2023 Apr 18, 2023	BUY	$9.2 - $12.26 $18,482 - $24,630	2,009 Added 2870.0%	2,079 $19,000
Q4 2022 Jan 11, 2023	BUY	$8.72 - $11.56 $8 - $11	1 Added 1.45%	70 $0
Q2 2022 Jul 20, 2022	SELL	$9.95 - $12.27 $2,218 - $2,736	-223 Reduced 76.37%	69 $1,000
Q1 2022 May 02, 2022	BUY	$9.81 - $15.4 $372 - $585	38 Added 14.96%	292 $3,000
Q4 2020 Jan 29, 2021	BUY	$14.3 - $18.74 $3,632 - $4,759	254 New	254 $5,000

1,095

965M

2.69M

2.34M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $13.7B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Macroview Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Macroview Investment Management LLC with notifications on news.